FTO and gastric cancer: Notably, FTO overexpression in gastric cancer is correlated with aggressive tumor phenotypes, including poor histological differentiation, lymphovascular invasion, advanced TNM stage, and advanced clinical stage, collectively underscoring its potential as a critical prognostic biomarker for disease progression and metastatic risk stratification [244].